Identifying opportunities for extracellular inhibition of ALK signaling
确定细胞外抑制 ALK 信号传导的机会
基本信息
- 批准号:10240717
- 负责人:
- 金额:$ 38.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptedAffectAmino AcidsAntibodiesArchitectureB-Cell ActivationBindingBiochemicalBiologicalBiological AssayBiophysicsCaenorhabditis elegansCellular AssayCessation of lifeChildhoodClinicalComplexComplex AnalysisCysteineDevelopmentDiseaseDrosophila genusEmbryonic DevelopmentEpitope MappingEpitopesFamilyFibronectinsFoundationsGeneticGenetic studyGlycineGoalsHomologous GeneImmunoglobulin FragmentsIn VitroInvertebratesKnowledgeLTK geneLeadLengthLigand BindingLigandsLinkLogicMalignant Childhood NeoplasmMalignant NeoplasmsMapsMass Spectrum AnalysisMediatingMolecularMonoclonal AntibodiesMutationNeuroblastomaNormal tissue morphologyOncogenicOutcomePathogenicityPathway interactionsPeptidesPeripheral Nervous SystemPhage DisplayPhosphotransferasesPlayProteinsReceptor ActivationReceptor Protein-Tyrosine KinasesReceptor SignalingRegulationRegulatory ElementReportingResearchSensorySignal PathwaySignal TransductionStructureSumSystemTechniquesTestingTherapeuticTherapeutic InterventionTranslatingVertebratesanaplastic lymphoma kinasebiophysical propertiesdesigndimerdisorder riskextracellularhigh riskinhibitor/antagonistinsightmembermutantneuron developmentnew therapeutic targetnovel therapeuticsoverexpressionpolyglycinepre-clinicalreceptorreceptor expressionreceptor functionrelating to nervous systemresponsetargeted treatmenttooltumorvirtual
项目摘要
Project Summary
This proposal aims to resolve the molecular basis for activation of an atypical receptor tyrosine kinase (RTK)
family – ALK. The ALK family consists of two receptors, ALK and LTK. ALKs are involved in neuronal
development and, like other RTKs, are critically important in numerous cancers. In particular, ALK is the
oncogenic driver in neuroblastoma – an aggressive and often lethal childhood cancer. Significantly, ALK
receptors are distinct from the 19 other RTK families (56 receptors in total). Perhaps most prominent, they do
not share the standard RTK architecture. Typically, RTKs are composed of multiple repeats of common domains
(e.g. Ig, fibronectin, cysteine-rich) in their extracellular region. On the contrary, ALK’s extracellular ‘sensory’
region is highly enriched in glycines (termed the glycine rich domain, GRD). Only recently the ALK GRD has
been shown to be a receiver for Augmentor (AUG) signals. Augmentors are small peptides with ~50 highly
conserved amino acids that are sufficient for stimulating ALKs kinase activity. Given ALK’s remarkable molecular
design, we expect ALK to have an equally distinguishable mechanism of receptor control – potentially broadening
the paradigm for RTK regulation. Despite the importance of this receptor family in cancer, surprisingly little is
known about how the receptor functions: 1) there are no reported structures for the GRD, AUG or their complex,
and 2) it remains unknown how engagement of ligand translates into receptor kinase activity. The research
proposed here focuses on understanding the molecular mechanism of ALK and LTK activation by AUG. With
this foundation we hope to reveal how oncogenic dysregulation usurps the control mechanisms in place during
normal development. Our goals over the next 10 years are: 1) To develop a complete mechanistic understanding
of how ALK receptors perceive Augmentors and transmit their signals, 2) To understand how receptor mutations
and matrix changes alter ALK signal transduction in cancer and 3) to determine if ALK’s unique structural and
regulatory elements present novel targets for therapeutic interventions. We will study ligand-receptor complexes
biochemically and with structural techniques, in order to understand in detail how AUG peptide binding leads to
activation of ALKs in the signaling complex. In pursuing studies of ALK’s activation, we will investigate how
preclinical monoclonal antibodies and discovered Fabs modulate and inhibit ALK function. In sum, our studies
will provide necessary fundamental insight into signaling by this unique family of receptors that does not fit into
the canonical RTK schema. Understanding the mechanism of receptor activation in this family will be crucial for
designing and deploying effective inhibitors that will need to differ from those targeting other well-studied RTKs.
In addition, our findings will reveal the signaling differences induced by common cancer mutations that will steer
clinical strategies to approach ALK dependent diseases.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daryl Ewald Klein其他文献
Daryl Ewald Klein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daryl Ewald Klein', 18)}}的其他基金
Identifying opportunities for extracellular inhibition of ALK signaling
确定细胞外抑制 ALK 信号传导的机会
- 批准号:
10674722 - 财政年份:2020
- 资助金额:
$ 38.32万 - 项目类别:
Identifying opportunities for extracellular inhibition of ALK signaling
确定细胞外抑制 ALK 信号传导的机会
- 批准号:
10407647 - 财政年份:2020
- 资助金额:
$ 38.32万 - 项目类别:
Harnessing receptor pleiotropy to control cancer
利用受体多效性来控制癌症
- 批准号:
9304532 - 财政年份:2017
- 资助金额:
$ 38.32万 - 项目类别:
Harnessing receptor pleiotropy to control cancer
利用受体多效性来控制癌症
- 批准号:
9751075 - 财政年份:2017
- 资助金额:
$ 38.32万 - 项目类别:
相似海外基金
How novices write code: discovering best practices and how they can be adopted
新手如何编写代码:发现最佳实践以及如何采用它们
- 批准号:
2315783 - 财政年份:2023
- 资助金额:
$ 38.32万 - 项目类别:
Standard Grant
One or Several Mothers: The Adopted Child as Critical and Clinical Subject
一位或多位母亲:收养的孩子作为关键和临床对象
- 批准号:
2719534 - 财政年份:2022
- 资助金额:
$ 38.32万 - 项目类别:
Studentship
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
- 批准号:
2633211 - 财政年份:2020
- 资助金额:
$ 38.32万 - 项目类别:
Studentship
A material investigation of the ceramic shards excavated from the Omuro Ninsei kiln site: Production techniques adopted by Nonomura Ninsei.
对大室仁清窑遗址出土的陶瓷碎片进行材质调查:野野村仁清采用的生产技术。
- 批准号:
20K01113 - 财政年份:2020
- 资助金额:
$ 38.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
- 批准号:
2436895 - 财政年份:2020
- 资助金额:
$ 38.32万 - 项目类别:
Studentship
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
- 批准号:
2633207 - 财政年份:2020
- 资助金额:
$ 38.32万 - 项目类别:
Studentship
The limits of development: State structural policy, comparing systems adopted in two European mountain regions (1945-1989)
发展的限制:国家结构政策,比较欧洲两个山区采用的制度(1945-1989)
- 批准号:
426559561 - 财政年份:2019
- 资助金额:
$ 38.32万 - 项目类别:
Research Grants
Securing a Sense of Safety for Adopted Children in Middle Childhood
确保被收养儿童的中期安全感
- 批准号:
2236701 - 财政年份:2019
- 资助金额:
$ 38.32万 - 项目类别:
Studentship
A Study on Mutual Funds Adopted for Individual Defined Contribution Pension Plans
个人设定缴存养老金计划采用共同基金的研究
- 批准号:
19K01745 - 财政年份:2019
- 资助金额:
$ 38.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Structural and functional analyses of a bacterial protein translocation domain that has adopted diverse pathogenic effector functions within host cells
对宿主细胞内采用多种致病效应功能的细菌蛋白易位结构域进行结构和功能分析
- 批准号:
415543446 - 财政年份:2019
- 资助金额:
$ 38.32万 - 项目类别:
Research Fellowships














{{item.name}}会员




